 |
 |
|
University of California, San Francisco | |
|
|
About UCSF | |
|
|
Search UCSF | |
|
|
UCSF Medical Center |
Tuesday, August 18, 2009
A team of scientists from UCSF and colleagues have identified a new potential
drug target for the herpes virus that causes Kaposi's sarcoma. Their
research reopens the possibility of using a class of drugs called
protease inhibitors, against diseases ranging from cancer to
Alzheimer's Disease. This research was published online in Nature
Chemical Biology, July 26, 2009. The lead author is Tina
Shahian, UCSF Graduate Group in Biochemistry and Molecular
Biology. Authors from the UCSF School of Pharmacy, Department of Pharmaceutical
Chemistry, are senior author Charles Craik, PhD, Gregory Lee, and Ana
Lazic. Other authors are colleagues from St. Judes Children's
Research Hospital.
UCSF researchers identify new drug target for Kaposi's Sarcoma
Go To: UCSF School of Pharmacy News
© 2002-2009 The Regents of the University of California.
See also Copyrights and Credits.
About privacy.
About accessibility.
Contact us.
Last updated: September 08, 2009 15:13:15 PDT
